Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

4.4K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.4K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

1.3K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.3K
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

729
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
729
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

JHEP reports : innovation in hepatology·2026
Same author

A Comprehensive Overview on Alopecia Areata with Review on Advances in Genetics and Treatment.

Indian journal of dermatology·2026
Same author

Optimizing Abrocitinib Use for Atopic Dermatitis in India: Expert Recommendations for Patient Selection, Dosing, and Long‑Term Remission.

Clinical, cosmetic and investigational dermatology·2026
Same author

Recent advances in detection techniques regarding predictive, prognostic, and diagnostic biomarkers in solid cancers and its future challenges.

Advances in cancer research·2026
Same author

Biomarkers for targeted therapy and treatment decision making.

Advances in cancer research·2026
Same author

Effectiveness of Abrocitinib in Cyclosporine-Resistant Atopic Dermatitis: A Real-world Experience from the Indian Subcontinent.

Indian journal of dermatology·2026

Related Experiment Video

Updated: Feb 13, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Acute Generalised Exanthematous Pustulosis: An Update.

Abhishek De1, Sudip Das1, Aarti Sarda2

  • 1Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India.

Indian Journal of Dermatology
|March 13, 2018
PubMed
Summary

Acute generalised exanthematous pustulosis (AGEP) is a severe drug-induced skin reaction. Early diagnosis and drug withdrawal are crucial for managing this rare condition, alongside supportive care and topical steroids.

Keywords:
Acute generalised exanthematous pustulosisadverse drug reactionpustular psoriasissevere cutaneous adverse reaction

More Related Videos

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

931
The Complete and Updated "Rotifer Polyculture Method" for Rearing First Feeding Zebrafish
08:52

The Complete and Updated "Rotifer Polyculture Method" for Rearing First Feeding Zebrafish

Published on: January 17, 2016

16.5K

Related Experiment Videos

Last Updated: Feb 13, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

931
The Complete and Updated "Rotifer Polyculture Method" for Rearing First Feeding Zebrafish
08:52

The Complete and Updated "Rotifer Polyculture Method" for Rearing First Feeding Zebrafish

Published on: January 17, 2016

16.5K

Area of Science:

  • Dermatology
  • Pharmacovigilance
  • Internal Medicine

Background:

  • Acute generalised exanthematous pustulosis (AGEP) is a severe cutaneous adverse drug reaction, predominantly linked to antibiotics.
  • This rare condition affects 1-5 individuals per million annually.
  • Clinical presentation includes rapid onset of sterile pustules, fever, and elevated white blood cell count.

Purpose of the Study:

  • To summarize the key aspects of Acute generalised exanthematous pustulosis (AGEP).
  • To highlight the importance of early diagnosis and management strategies for AGEP.
  • To underscore the role of drug causality in AGEP development.

Main Methods:

  • Review of clinical manifestations and histopathological findings in AGEP.
  • Analysis of causative agents, with a focus on frequently implicated drugs like antibiotics.
  • Examination of diagnostic criteria and management principles for AGEP.

Main Results:

  • AGEP is characterized by sterile pustules, fever, and leukocytosis.
  • Drug-induced etiology is identified in over 90% of AGEP cases.
  • Histopathology reveals intraepidermal pustules, dermal edema, and inflammatory infiltrates.

Conclusions:

  • Prompt identification and cessation of the offending drug are paramount in AGEP management.
  • Supportive care, avoidance of implicated antibiotics, and potent topical steroids are recommended treatments.
  • Understanding AGEP is crucial for minimizing morbidity associated with severe cutaneous adverse reactions.